(Q42545745)

2 November 2017

title

Novel NMDA/glycine site antagonists attenuate cocaine-induced behavioral toxicity (English)

1 reference

2 November 2017

Matsumoto RR

1

1 reference

2 November 2017

Brackett RL

series ordinal

2

1 reference

2 November 2017

Kanthasamy AG

series ordinal

3

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

European Journal of Pharmacology

2 November 2017

published in

1 reference

2 November 2017

volume

338

1 reference

2 November 2017

issue

3

1 reference

2 November 2017

page(s)

233-242

1 reference

Clinical pharmacology and toxicology of cocaine

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

NMDA receptors are involved at the ventrolateral nucleus tractus solitarii for termination of inspiration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

Neuronal loss induced in limbic pathways by kindling: evidence for induction of hippocampal sclerosis by repeated brief seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

Anticonvulsant modification of cocaine-induced toxicity in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

The N-methyl-D-aspartate (NMDA) receptor glycine site antagonist ACEA 1021 does not produce pathological changes in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

Synthesis and structure-activity relationships of substituted 1,4-dihydroquinoxaline-2,3-diones: antagonists of N-methyl-D-aspartate (NMDA) receptor glycine sites and non-NMDA glutamate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

Over-additive protective effect of dizocilpine and NBQX against neuronal damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

Attenuation of nociceptive responses by ACEA-1021, a competitive NMDA receptor/glycine site antagonist, in the mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

Strychnine-insensitive glycine site antagonists attenuate a cardiac arrest-induced movement disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

One-way cross-sensitization and cross-tolerance to seizure activity from cocaine to lidocaine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

Probenecid pretreatment enhances anticonvulsant action of NBQX in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

Seizures, brain damage and brain development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

D-cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

Cocaine-induced psychosis and sudden death in recreational cocaine users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

Modulators of N-methyl-D-aspartate protect against diazepam- or phenobarbital-resistant cocaine convulsions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

The co-agonist concept: is the NMDA-associated glycine receptor saturated in vivo?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline enhances the protective activity of common antiepileptic drugs against maximal electroshock-induced seizures in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981926-7

10.1016/S0014-2999(97)81926-7

7 January 2021

Identifiers

DOI

1 reference

2 November 2017

1 reference